Mergers & Acquisitions
M&A Healthcare Advisors
Regulated assets, clinical reality, disciplined transactions.
Handle’s healthcare M&A advisory supports investors and operators acquiring hospitals, clinics and laboratories — combining regulatory and licensing review, clinical and service-line assessment and financial modelling so healthcare deals are compliant and built for continuity of care.
When this is needed
Healthcare M&A Advisory in the UAE: where the mandate begins.
- An investor is evaluating a hospital, clinic or laboratory and needs to understand licensing and compliance exposure.
- Valuation depends on reimbursement, occupancy or clinical quality assumptions that must be tested.
- A healthcare acquisition requires health-authority approvals that could reshape timing or ownership.
- Patients, clinicians and staff must transition to a new owner without disrupting care.
Matters Handle leads
Healthcare transaction mandates.
Four mandate types. One compliant healthcare transaction.
Healthcare Sector Strategy
Market position, service mix and competitive context.
Regulatory & Licensing Review
Licensing, inspections, accreditation and compliance history.
Clinical & Operational Review
Clinical services, capacity and quality processes.
Transition Planning
Patient, staff and stakeholder transition after completion.
The scope
M&A Healthcare Advisors — scope, made explicit.
A focused, premium mandate — with patient safety and continuity of care at the center.
Sub-Sector Analysis
Hospital, clinic and laboratory markets assessed.
Service Line Assessment
Clinical capability, case mix and capacity reviewed.
Regulatory Diligence
Approvals, licensing and accreditation tested across health authorities.
Value & Risk Modelling
Forecasts that connect clinical reality to financial outcomes.
Transaction Structuring
Deal structure, value drivers and post-transaction priorities defined.
The mandate
Healthcare deals, read clinically.
Healthcare transactions carry obligations that standard deal processes miss. Handle reviews licensing, clinical quality, staffing and reimbursement alongside the financials, so investors see the full risk of a regulated asset.
Structure, approvals and transition plans are designed together. Patients, clinicians and regulators experience continuity while ownership changes.
What the mandate delivers
- Clinical capability and service line assessment
- Regulatory and licensing review
- Patient safety and quality evaluation
- Healthcare financial and operational modelling
- Clinical and operational risk mapping
- Healthcare transition pathways
How the work runs
Four disciplines. One compliant healthcare deal.
Every healthcare M&A mandate is run with clinical, regulatory, financial and transition control.
01
Clinical Review
Services, quality and capacity assessed in structure.
02
Regulatory Diligence
Approvals, inspections and compliance exposure reviewed.
03
Value Modelling
Utilisation, case mix and reimbursement linked to value.
04
Transition Planning
Care pathways and staffing protected through completion.
The Handle model
Practice-led. Never fragmented.
The transaction may begin here — it stays connected to strategy, capital and law.
Strategy & Operations
The work stays connected to market position, operating model, performance and execution governance.
M&A & Capital
The work stays aware of capital readiness, investor review, transaction logic and deployment discipline where relevant.
Legal & Regulatory
The work stays protected through structure, rights, governance, enforceability and regulatory or dispute readiness.
Why Handle
Sector depth. Deal discipline.
Handle combines healthcare sector understanding with transaction discipline — and connects every deal to the capital plan and long-term service delivery behind the asset.
- Clinical and service line assessment
- Health-authority regulatory and licensing review
- Reimbursement and utilisation-driven valuation
- Patient and staff transition planning
- Data privacy and healthcare technology awareness
- Partner-led mandates with institutional discipline
Before offering your business for M&A, you must raise it with discipline. Strengthen governance, restore financial clarity, and sharpen strategy. A parented business attracts investors with confidence, not discounts.
Mohamed abu El-MakaremManaging Partner & Chairman
Engagement paths
Where this work typically begins.
Growth & Expansion
When the asset must scale capacity, geography, capital, partnerships or market share.
Turnaround
When the asset must reset structure, capital, law, governance and operations under pressure.
Coverage
Connected across the transaction practice.
Handle’s healthcare M&A advisory serves investors and operators acquiring or combining healthcare assets in the UAE and the wider region.
Related service lines · Mergers & Acquisitions
M&A topics · Explore further
Across the Handle model
Questions, answered
Healthcare M&A Advisory — questions, answered.
How Handle’s healthcare M&A advisory manages regulated transactions.
What makes healthcare M&A different?
Healthcare deals involve strict regulation, clinical standards, licensing and patient care obligations.
Which areas matter most in healthcare M&A advisory?
Compliance, licensing, clinical quality, reimbursement models, insurance and data privacy.
How does regulation affect healthcare transactions?
It influences ownership limits, approvals, service obligations and post-closing integration.
How are healthcare businesses valued?
Valuations weigh reimbursement risk, clinical quality indicators, occupancy and long-term contracts.
What are the main risks in healthcare deals?
Regulatory exposure, staffing shortages, clinical liabilities and reimbursement changes.
Is clinical review part of healthcare M&A advisory?
Yes. Clinical review is essential to understand operational and regulatory implications.
Does healthcare due diligence take longer?
Often, because of regulatory compliance requirements and data sensitivity.
Why does culture matter in healthcare M&A?
Culture shapes patient care standards and staff retention.
How does technology affect healthcare transactions?
It drives data privacy compliance, billing systems and care delivery models.
What is Handle’s role in healthcare M&A?
Handle evaluates clinical, regulatory and financial risk and structures transactions for compliance and continuity.
Insights
Perspectives from live mandates.
Partner-led analysis on law, capital and strategy, shaped by boardroom realities across the UAE and the GCC.
Work with Handle
Begin with M&A Healthcare Advisors — kept connected to the whole Handle model.
When a healthcare asset must change hands without disrupting care.
Request an initial review
When a healthcare transaction must be structured with precision.
Set out the matter. A partner reviews it and responds with a defined route, strategy and accountable lead.
- Partner-level review of every request
- Strict confidentiality and privilege from first contact
- One accountable partner from review to execution



